On November 11, Synopsys fell 3.12% in Regular Trading, trading at $452.49 per share, with turnover of $203 million.
The latest publicly available catalyst tied to the move is continued market digestion of recent analyst target-price increases after a prior sentiment boost, with short-term volatility emerging despite a still-supportive sell-side backdrop.
Recent analyst actions remained constructive: Rothschild & Co Redburn raised its target price to $615 from $550, above the broader analyst mean target of $594.87, while Needham, KeyBanc, and Morgan Stanley had also lifted targets to $620, $605, and $574, respectively. Earlier supporting developments included Synopsys outlining fiscal 2027 revenue of about $11.15 billion at the midpoint, a plan to return up to 50% of free cash flow through repurchases, and a $1 billion accelerated share repurchase agreement.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments